A review of consent practices and perspectives for pharmacogenetic testing

Aim: We aimed to understand consent practices for pharmacogenetic (PGx) testing.

Methods: We conducted a literature review and analysis of consent forms from clinical laboratories offering PGx testing.

Results: Our review of the literature shows a lack of consensus about the need for and type of informed consent for PGx testing. We identified 35 companies offering PGx testing and were able to confirm consent practices for 22 of those. We found a range of variability in the consent practices regarding the consent approach and information disclosed.

Conclusion: Variability in the consent practices among laboratories offering PGx testing mirrors the ambiguous practices and recommendations reported in the literature. Establishing a minimal set of information to be disclosed to patients may help address the disparities in consent practice.

Keywords: communication; consent; pharmacogenetic testing; pharmacogenetics.

Conflict of interest statement

Financial & competing interests disclosure SB Haga serves as a consultant to Mako Medical Laboratories (Raleigh, NC, USA) and the Inova Translational Medicine Institute (Falls Church, VA, USA). The authors are partly supported by the US NIH (1R01GM081416). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

Similar articles

Hoffecker G, Kanter GP, Xu Y, Matthai W, Kolansky DM, Giri J, Tuteja S. Hoffecker G, et al. Per Med. 2022 Jan;19(1):41-49. doi: 10.2217/pme-2021-0088. Epub 2021 Dec 9. Per Med. 2022. PMID: 34881641

Pritchard D, Patel JN, Stephens LE, McLeod HL. Pritchard D, et al. Am J Health Syst Pharm. 2022 Jun 7;79(12):993-1005. doi: 10.1093/ajhp/zxac064. Am J Health Syst Pharm. 2022. PMID: 35230418 Free PMC article.

Luczak T, Brown SJ, Armbruster D, Hundertmark M, Brown J, Stenehjem D. Luczak T, et al. Pharmacogenomics. 2021 Apr;22(6):345-364. doi: 10.2217/pgs-2020-0181. Epub 2021 Apr 8. Pharmacogenomics. 2021. PMID: 33829852 Review.

Pratt VM, Cavallari LH, Del Tredici AL, Gaedigk A, Hachad H, Ji Y, Kalman LV, Ly RC, Moyer AM, Scott SA, van Schaik RHN, Whirl-Carrillo M, Weck KE. Pratt VM, et al. J Mol Diagn. 2021 Sep;23(9):1047-1064. doi: 10.1016/j.jmoldx.2021.05.013. Epub 2021 Jun 10. J Mol Diagn. 2021. PMID: 34118403 Free PMC article. Review.

Abdel-Latif R, Badji R, Mohammed S, Al-Muftah W, Mbarek H, Darwish D, Assaf D, Al-Badriyeh D, Elewa H, Afifi N, Masoodi NA, Omar AS, Al Suwaidi J, Bujassoum S, Al Hail M, Ismail SI, Althani A. Abdel-Latif R, et al. Clin Transl Sci. 2024 Jun;17(6):e13800. doi: 10.1111/cts.13800. Clin Transl Sci. 2024. PMID: 38818903 Free PMC article. Review.

Cited by

Pereira L, Haidar CE, Haga SB, Cisler AG, Hall A, Shukla SK, Hebbring SJ, Leary EJW. Pereira L, et al. Front Pharmacol. 2024 Feb 8;15:1355412. doi: 10.3389/fphar.2024.1355412. eCollection 2024. Front Pharmacol. 2024. PMID: 38410134 Free PMC article.

Aboelbaha S, Zolezzi M, Abdallah O, Eltorki Y. Aboelbaha S, et al. Pharmgenomics Pers Med. 2023 May 30;16:503-518. doi: 10.2147/PGPM.S410240. eCollection 2023. Pharmgenomics Pers Med. 2023. PMID: 37274729 Free PMC article.

Cicali EJ, Lemke L, Al Alshaykh H, Nguyen K, Cavallari LH, Wiisanen K. Cicali EJ, et al. J Am Coll Clin Pharm. 2022 Nov;5(11):1161-1175. doi: 10.1002/jac5.1699. Epub 2022 Aug 27. J Am Coll Clin Pharm. 2022. PMID: 36589694 Free PMC article.

Nabukenya S, Ochieng J, Kaawa-Mafigiri D, Munabi I, Nakigudde J, Nakwagala FN, Barugahare J, Kwagala B, Ibingira C, Twimwijukye A, Sewankambo N, Mwaka ES. Nabukenya S, et al. Res Ethics. 2022 Jul;18(3):193-209. doi: 10.1177/17470161221076974. Epub 2022 Feb 7. Res Ethics. 2022. PMID: 36213304 Free PMC article.

Haga SB. Haga SB. Front Genet. 2021 Oct 1;12:741395. doi: 10.3389/fgene.2021.741395. eCollection 2021. Front Genet. 2021. PMID: 34659361 Free PMC article.

References

    1. Haga SB, Moaddeb J. Comparison of delivery strategies for pharmacogenetic testing services. Pharmacogenet. Genomics. 2014;24(3):139–145. - PMC - PubMed
    1. Dunnenberger HM, Crews KR, Hoffman JM, et al. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. Annu. Rev. Pharmacol. Toxicol. 2015;55:89–106. - PMC - PubMed
    1. Institute of Medicine. Crossing the Quality Chasm: a New Health System for the 21st Century. National Academy Press; Washington, DC, USA: 2001. - PubMed
    1. American Medical Association. Opinion 8.08 - Informed Consent. www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medical.
    1. Coleman CH, Selgelid MJ, Reis A, Reichman LB, Jaramillo E. The role of informed consent in tuberculosis testing and screening. Eur. Respir. J. 2012;39(5):1057–1059. - PubMed